Objectives: To elucidate the clinical and pathologic features of extra
hepatic cholangiocarcinomas and to identify prognostic variables in pa
tients treated surgically. Design: Retrospective review of clinical re
cords of patients undergoing surgical exploration for cholangiocarcino
ma, with univariate and multivariate analyses of the clinical and path
ologic factors that influenced patient survival. Setting: Mayo Clinic,
Rochester, Minn. Study Participants: One hundred seventy-one patients
undergoing operative intervention for diagnostic, palliative, or cura
tive reasons between 1976 and 1985. Follow-up was complete until death
or for a minimum of 5 years for surviving patients. Intervention: A c
urative surgical resection was performed in 29% of patients, while the
remainder underwent tumor biopsy or a palliative procedure. Main Outc
ome Measure: Patient survival following operative treatment. Results:
The operative mortality in this patient cohort was 5% and median survi
val was 13 months. Overall 5-year survival was 16%, with 44% of patien
ts having a curative resection still alive at 5 years. Using univariat
e analysis, curative resection, tumor stage, Eastern Cooperative Oncol
ogy Group performance status, total bilirubin concentration, lymph nod
e status, liver invasion, tumor morphology, tumor grade, and site of t
umor origin were significant determinants of prognosis. Using the Cox
proportional hazards model for multivariate analysis, curative resecti
on, Eastern Cooperative Oncology Group performance status, total bilir
ubin concentration, and tumor grade were the only variables predictive
of patient outcome. A curative resection of a proximal cholangiocarci
noma had a similar chance of providing long-term survival as a curativ
e distal ductal resection. Conclusions: Although the tumor extent and
the patient's overall health will affect outcome, curative resection f
or cholangiocarcinoma at all sites should be undertaken since this tre
atment offers the best chance for long-term survival.